Kenneth Ferguson

Kenneth Ferguson

Director/Board Member en CYCLACEL PHARMACEUTICALS, INC. .

68 años
Health Technology
Consumer Services
Finance

Perfil

Kenneth M.
Ferguson
is currently the Director at Cyclacel Pharmaceuticals, Inc. and an Operating Partner at Accelerator Services Corp.
Previously, he was the President, Chief Executive Officer & Director at Vactx International, Inc. from 2008 to 2010, COO, Chief Scientific Officer & Director at Lilly ICOS LLC, and President at ICOS Corp.
from 1990 to 2007.
He also served as the Chief Development Officer & Vice President at Omeros Corp.
from 2012 to 2017 and as the Chief Scientific Officer at EMulate Therapeutics, Inc. Dr. Ferguson received his undergraduate degree from Cornell University and his doctorate from Texas University of Health Center at San Antonio.

Cargos activos de Kenneth Ferguson

EmpresasCargoInicio
CYCLACEL PHARMACEUTICALS, INC. Director/Board Member 14/06/2022
Private Equity Investor -
Todos los cargos activos de Kenneth Ferguson

Antiguos cargos conocidos de Kenneth Ferguson.

EmpresasCargoFin
OMEROS CORPORATION Corporate Officer/Principal 01/05/2017
Vactx International, Inc. Chief Executive Officer 01/11/2010
President 01/12/2007
Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer -
Ver el detalle de la experiencia de Kenneth Ferguson.

Formación de Kenneth Ferguson.

Cornell University Undergraduate Degree
Texas University of Health Center at San Antonio Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kenneth Ferguson.

Relaciones

83

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
OMEROS CORPORATION

Health Technology

CYCLACEL PHARMACEUTICALS, INC.

Health Technology

Empresas privadas5

Health Technology

Health Technology

Health Technology

Finance

Vactx International, Inc.

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Kenneth Ferguson